IN2014MN01795A - - Google Patents
Download PDFInfo
- Publication number
- IN2014MN01795A IN2014MN01795A IN1795MUN2014A IN2014MN01795A IN 2014MN01795 A IN2014MN01795 A IN 2014MN01795A IN 1795MUN2014 A IN1795MUN2014 A IN 1795MUN2014A IN 2014MN01795 A IN2014MN01795 A IN 2014MN01795A
- Authority
- IN
- India
- Prior art keywords
- patient
- biological fluid
- percentage
- bcl2l10 protein
- sample
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5748—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncogenic proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57426—Specifically defined cancers leukemia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/82—Translation products from oncogenes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/54—Determining the risk of relapse
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Analysing Materials By The Use Of Radiation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1200584A FR2987446B1 (fr) | 2012-02-28 | 2012-02-28 | Test diagnostic de la resistance a l'azacitidine |
PCT/FR2013/000055 WO2013128089A1 (fr) | 2012-02-28 | 2013-02-28 | Test diagnostic de la résistance à l'azacitidine |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014MN01795A true IN2014MN01795A (zh) | 2015-07-03 |
Family
ID=48083449
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN1795MUN2014 IN2014MN01795A (zh) | 2012-02-28 | 2013-02-28 |
Country Status (11)
Country | Link |
---|---|
US (1) | US20150094217A1 (zh) |
EP (1) | EP2820417A1 (zh) |
JP (1) | JP6273552B2 (zh) |
CN (1) | CN104321649A (zh) |
AU (1) | AU2013224832A1 (zh) |
BR (1) | BR112014021173A2 (zh) |
CA (1) | CA2865684A1 (zh) |
FR (1) | FR2987446B1 (zh) |
IL (1) | IL234332A0 (zh) |
IN (1) | IN2014MN01795A (zh) |
WO (1) | WO2013128089A1 (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3042650B1 (en) * | 2014-03-27 | 2020-06-10 | Palacky University, Olomouc | Bromodomain inhibitor jq1 in combination with dna methylation inhibitor dac for use in cancer treatment |
FR3048698B1 (fr) * | 2016-03-11 | 2021-03-05 | Univ Claude Bernard Lyon | Inhibiteurs de l'interaction bcl2 l10 / recepteur ip3 |
WO2019077080A1 (en) * | 2017-10-19 | 2019-04-25 | Universite Claude Bernard Lyon 1 | ASSESSING THE RISK OF METASTATIC RECHUTE IN PATIENTS WITH BREAST CANCER |
CN114874987A (zh) * | 2022-03-01 | 2022-08-09 | 洛阳市中心医院(郑州大学附属洛阳中心医院) | 一种骨髓异常增生综合征耐药细胞模型及其构建方法和用途 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2005078100A1 (ja) | 2004-02-13 | 2007-08-30 | 稲澤 譲治 | 薬剤耐性を獲得した癌細胞の検出方法 |
ES2550614T3 (es) | 2004-04-09 | 2015-11-11 | Genomic Health, Inc. | Marcadores de expresión génica para predecir la respuesta a la quimioterapia |
WO2010045651A1 (en) * | 2008-10-17 | 2010-04-22 | Nodality, Inc. | Methods for analyzing drug response |
CN101632643A (zh) * | 2009-08-18 | 2010-01-27 | 杭州咸达医药科技有限公司 | 阿扎胞苷冻干粉针制剂及其制备方法 |
JP5190477B2 (ja) * | 2010-02-22 | 2013-04-24 | 譲治 稲澤 | カンプトテシン類の制癌剤に対する薬剤耐性を獲得した肺癌細胞の検出方法 |
WO2011147976A1 (en) * | 2010-05-27 | 2011-12-01 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for assessing endometrium receptivity of a patient |
-
2012
- 2012-02-28 FR FR1200584A patent/FR2987446B1/fr not_active Expired - Fee Related
-
2013
- 2013-02-28 EP EP13715265.8A patent/EP2820417A1/fr not_active Withdrawn
- 2013-02-28 IN IN1795MUN2014 patent/IN2014MN01795A/en unknown
- 2013-02-28 CN CN201380013105.4A patent/CN104321649A/zh active Pending
- 2013-02-28 US US14/381,406 patent/US20150094217A1/en not_active Abandoned
- 2013-02-28 BR BR112014021173A patent/BR112014021173A2/pt not_active IP Right Cessation
- 2013-02-28 AU AU2013224832A patent/AU2013224832A1/en not_active Abandoned
- 2013-02-28 JP JP2014559271A patent/JP6273552B2/ja not_active Expired - Fee Related
- 2013-02-28 WO PCT/FR2013/000055 patent/WO2013128089A1/fr active Application Filing
- 2013-02-28 CA CA2865684A patent/CA2865684A1/fr not_active Abandoned
-
2014
- 2014-08-27 IL IL234332A patent/IL234332A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN104321649A (zh) | 2015-01-28 |
JP2015513369A (ja) | 2015-05-11 |
EP2820417A1 (fr) | 2015-01-07 |
IL234332A0 (en) | 2014-10-30 |
BR112014021173A2 (pt) | 2017-08-22 |
FR2987446B1 (fr) | 2016-01-01 |
JP6273552B2 (ja) | 2018-02-07 |
AU2013224832A8 (en) | 2014-11-13 |
AU2013224832A1 (en) | 2014-10-16 |
WO2013128089A1 (fr) | 2013-09-06 |
US20150094217A1 (en) | 2015-04-02 |
FR2987446A1 (fr) | 2013-08-30 |
CA2865684A1 (fr) | 2013-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201903597B (en) | Biosensors for biological or chemical analysis and methods of manufacturing the same | |
CY1120434T1 (el) | Πρωτεϊνες προσδεσης il-1 | |
WO2013190075A3 (en) | Specific biomarkers for hepatocellular carcinoma (hcc) | |
SG10201903822XA (en) | Method for the enrichment of circulating tumor dna | |
EA201590247A1 (ru) | Антитела к siglec-15 | |
SG11201500371VA (en) | Methods of detecting dna, rna and protein in biological samples | |
PL2986735T3 (pl) | Sposób określania składu ilościowego komórek krwi w próbce | |
MX2016011377A (es) | Metodo para diagnosticar cancer colorrectal a partir de una muestra de heces humanas por pcr cuantitativa, cebadores y equipo. | |
MY167920A (en) | HUMAN ANTIBODIES TO GFRα3 AND METHODS OF USE THEREOF | |
WO2012122564A3 (en) | Diagnostic and sample preparation devices and methods | |
MX357429B (es) | Predictores para el tratamiento del cáncer. | |
EP3287791A4 (en) | BLOOD SAMPLE COAGULATION CAPACITY ASSESSMENT METHOD, AND REAGENT, REAGENT KIT AND DEVICE FOR USE THEREIN | |
ZA201402460B (en) | Assembly for determining the presence or absence of an analyte in a blood sample and analysis unit comprising such an assembly | |
IN2014MN01795A (zh) | ||
EP2569635A4 (en) | METHODS OF DIAGNOSING AND TREATING ENCEPHALITY OR EPILEPSY | |
EP2909589A4 (en) | DEVICE AND METHOD FOR ULTRASCHALLANALISM OF BIOLOGICAL SAMPLES | |
WO2015013508A3 (en) | Methods for diagnosing and treating immune disease | |
SG11201700876RA (en) | Methods and compositions for analyzing glucose-6-phosphate dehydrogenase activity in blood samples | |
WO2014053996A3 (en) | Antibodies to microbiome, stress factors and mast cell markers as diagnostic markers for ibs | |
MX2015003740A (es) | Metodo para evaluar la reaccion de coagulacion sanguinea. | |
MX2021009528A (es) | Prueba de diagnostico basada en fragmento de rgma. | |
PT3155421T (pt) | Recipiente para determinar analitos e/ou parâmetros físicoquímicos, bem como para determinar o sedimento urinário na urina, e método de análise completa da urina utilizando este recipiente | |
HK1183064A1 (zh) | 生物樣品中待檢物的夾心免疫 檢測方法和試劑盒 | |
WO2012131092A3 (en) | Method and kits for the prediction of response/nonresponse to the treatment with an anti-egfr antibody in patients with colorectal cancer of all uicc stages | |
MX366272B (es) | Metodos y composiciones para diagnosticar preeclampsia. |